Professor Fereidoun Azizi
Born in 1942, in Tehran, the capital city of Iran, Fereidoun Azizi obtained his MD from Tehran University, School of Medicine in 1966, Dr. Azizi then completed his internal medicine speciality, endocrinology and methabolism subspeciality and nuclear medicine speciality from Tufts University, School of Medicine, Boston, USA and obtained three American Boards of Internal Medicine, Endocrinology and Metabolism, and Nuclear Medicine in 1972, 1973 and 1974, respectively. He was appointed assistant professor of medicine at Tufts University, and Chief of Endocrinology and acting-chief of Nuclear Medicine at St. Elizabeth’s Hospital of Boston, Tufts Medical School from 1974 until 1979, when he returned to Iran. He began his affilation with Beheshti University, and has since served as associate professor in 1979 and as professor of medicine and endocrinology since 1985. His appointements have been Dean of the medical school, Chancellor of Shahid Beheshti University of Medical Sciences, Head of the medical group of Supreme Council for Educational Programming and Director of Medical Commission of Council for Scientific Research in the Islamic Republic of Iran. He has served as President of Iranian College of Internal Medicine and is currently the president of the Iran Endocrine Society.
Professor Azizi has been the Leading Professor and Director of Endocrine Division at Taleghani Medical center, Shahid Beheshti University of Medical Sciences since 1989 and Director of Endocrine Research Center since 1994. He has had a large endocrine practice since 1979.
Professor Azizi’s many research contributions have been in various fields of endocrinology and metabolism, in particular the hypothalamic-pituitary-thyroid axis. He began his work with Professor L.E. Braverman in Boston and continued his interest in thyroid pathophysiology in Iran. He focused many of his research projects in 80’s in iodine deficiency in Iran, presented the results to the Minister of Health of Iran in 1988 and initiated the first national IDD survey, which led to the formation of National Council for Control of Iodine Deficiency Disorders in Iran in 1989; as the head of this council, he has been working with all related officials of the government for monitoring of IDD programs, in order to ensure sustained elimination of iodine deficiency in the last 20 years in Iran. He also directed the national research project of Tehran Lipid and Glucose Study in the last 14 years.
Professot Azizi was the Regional Coordinator for the Middle East and North Africa of Internaltional Council for Control of Iodine Deficiency Disorders (ICCIDD) and has served as consultant and advisor to WHO and UNICEF on multiple occasions. He is the Editor-in-Chief of the International Journal of Endocrinology and Metabolism. Professor Azizi has 1630 publications including 930 peer reviewed international paper and 700 scientific papers in Iranian medical Journals and 30 full text or chapters in scientific books. He is an invited reviewer for more than 26 scientific medical journals. He has received many awards including five awards from presidents of I.R. Iran for “Distinguished Professor”, “Research Excellence”, “Kharazmi Festival”, “Distinguished Research Center”and “Health Promition” in 1992, 1994, 1997, 2002 and 2008; State of Kwait Prize for excellence in diabetes in Eastern Mediterranean Region in 2007 and Nagataki Prize from Asia-Oceania Congress of Endocrinology in 2009. He was selected, as Distinguished Scienctist of the Year by Iranian Academy of Medical Sciences in 2011. Professor Azizi has been announced as “the most prominent scientist of the Islamic World by ISC in 2009, 2011 and 2013. He received Allameh Tabatabai Prize from the president of the Islamic Republic of Iran in 2012 and Razi National Research Award from Vice-President of the Islamic Republic of Iran in 2015.